Pricing Log in Create free account

Entera Bio Ltd. (ENTX) vs Indaptus Therapeutics, Inc. (INDP)

Entera Bio Ltd. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Entera Bio Ltd. and Indaptus Therapeutics, Inc. are of similar size ($530.5M and $497.6M). Across the 8 metrics below, Entera Bio Ltd. leads on 4 and Indaptus Therapeutics, Inc. on 4.

Valuation

Metric ENTX INDP Biotechnology median
P/E n/m n/m 10.64
P/S 694.55 n/m 9.59
P/B 21.32 33.39 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 629.36 n/m 9.45
Earnings yield (11.40%) (236.87%) (34.69%)
Free cash flow yield (7.10%) (3.87%) (24.02%)

Profitability

Metric ENTX INDP Biotechnology median
Gross margin 0.00% 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.92%) (318.04%) (51.96%)
Return on assets (87.02%) (163.84%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTX INDP Biotechnology median
Revenue growth (TTM) 66.42% — 4.59%
EPS growth (last fiscal year) 0.00% 52.15% 29.88%
Revenue growth, 5-year CAGR (29.19%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 19.48 4.86
Net debt to EBITDA 1.29 0.43 1.01

Dividend

Metric ENTX INDP Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ENTX INDP Biotechnology median
Market cap 530.46m 497.60m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack